Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA

NCT ID: NCT03054064

Last Updated: 2020-04-07

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-02-21

Study Completion Date

2018-01-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the safety and effectiveness of the Indego exoskeleton as a gait training tool for individuals with hemiplegia due to Cerebrovascular Accident (CVA).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebrovascular Accident (CVA) Stroke Hemiplegia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All Enrolled Subjects

All enrolled subjects will receive gait training with the Indego.

Group Type EXPERIMENTAL

Indego Exoskeleton

Intervention Type DEVICE

Six study sessions including five Indego training sessions over two weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Indego Exoskeleton

Six study sessions including five Indego training sessions over two weeks.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Height 5'1" to 6'3" (acceptable height may vary by a few inches depending on femur length)
* Weight 250 pounds or less
* History of one sided ischemic or hemorrhagic stroke with resultant hemiparesis
* Manual Muscle Test (MMT) 4/5 in at least upper extremity
* No restrictions on time since stroke (acuity), but all subjects need to be cleared by MD for locomotor training
* No other brain abnormalities or neurological diseases/disorders
* Has not been diagnosed with more than one stroke
* Passive range of motion (PROM) at shoulders, trunk, hips, knees and ankles within functional limits for safe gait
* Skin intact where interfaces with Indego device
* Modified Ashworth Scale (MAS) for spasticity 3 or less in the lower extremities
* Absence of complicating physical or mental conditions as determined by MD that would preclude the individual from safely participating in gait training
* Must be able to follow directions and communicate basic needs, demonstrated by a Mini- Mental State Exam (MMSE) score of 18 or greater

* Pregnancy
* Colostomy bag
* Uncontrolled/untreated hyper- or hypotension
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shepherd Center, Atlanta GA

OTHER

Sponsor Role collaborator

Cedars-Sinai Medical Center

OTHER

Sponsor Role collaborator

Sheltering Arms Physical Rehabilitation Hospitals

OTHER

Sponsor Role collaborator

Shirley Ryan AbilityLab

OTHER

Sponsor Role collaborator

Kessler Foundation

OTHER

Sponsor Role collaborator

St. Charles Hospital

UNKNOWN

Sponsor Role collaborator

TIRR Memorial Hermann

OTHER

Sponsor Role collaborator

Rusk Rehabilitation

UNKNOWN

Sponsor Role collaborator

Parker Hannifin Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cedars-Sinai Health System

Los Angeles, California, United States

Site Status

Shepherd Center

Atlanta, Georgia, United States

Site Status

Rehabilitation Institute of Chicago (Shirley Ryan AbilityLab)

Chicago, Illinois, United States

Site Status

Kessler Foundation

West Orange, New Jersey, United States

Site Status

St. Charles Hospital

Port Jefferson, New York, United States

Site Status

TIRR Memorial Hermann

Houston, Texas, United States

Site Status

Sheltering Arms Physical Rehabilitation Centers

Mechanicsville, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PHIND_CVA01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Robotic Exoskeleton Assisted Gait Post Stroke
NCT04309305 ENROLLING_BY_INVITATION PHASE1
Ankle Exoskeleton for Stroke Gait Enhancement
NCT07179627 NOT_YET_RECRUITING NA
Safety and Feasibility of ExoNET
NCT05180812 ACTIVE_NOT_RECRUITING NA